Efficacy of alogliptin on serum lipid profile according to glycemic control in Japanese patients with type 2 diabetes

Efficacy of alogliptin on serum lipid profile according to glycemic control in Japanese patients with type 2 diabetes - Efficacy of alogliptin on serum lipid profile

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015267

Enrollment

130

Registered

2014-09-26

Start date

2010-08-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Alogliptin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetes patients. Obtained written informed consent from the patients before participation.

Exclusion criteria

Exclusion criteria: Complicated with severe nephropathy.

Design outcomes

Primary

Measure	Time frame
Blood hemoglobin A1c, and serum total cholesterol, HDL cholesterol, LDL cholesterol, and triglyceride levels	—

Secondary

Measure	Time frame
Casual blood glucose level	—

Countries

Japan

Contacts

Public ContactMasataka Kusunoki

Aichi Medical University Department of Internal Medicine, Medical Clinic

info@tonyo.jp052-931-2261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026